Corpus 1,285 assessed · 1,186 scored · 647 reproduced ≥75 · 174 flagged ·∅ 73.9/100

Publications 2 Datasets 392.5k Experiments 6.2k

Explore

Filters: Tianjin Medical University Cancer Institute and Hospital ✕ 2023 ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer. PMID 38076064	Heliyon	2023	71	L1 71/100
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells. PMID 37231145	NPJ Precis Oncol	2023	40	L1 40/100

Assessment tool based on fatty acid metabolic signatures for predicting the prognosis and treatment response in bladder cancer.

PMID 38076064 · Heliyon · 2023

L1 71/100

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.

PMID 37231145 · NPJ Precis Oncol · 2023

L1 40/100